PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR

[Problem(s)] It is an object of the present invention to provide a pharmaceutical composition for treatment or prevention for the early stage of osteoarthritis and its manufacturing method. [Means for solving problem(s)] The present invention is based on a knowledge that the use of an anti-Fas IgM a...

Full description

Saved in:
Bibliographic Details
Main Authors NISHIOKA KUSUKI, YUDO KAZUO
Format Patent
LanguageEnglish
Korean
Published 17.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [Problem(s)] It is an object of the present invention to provide a pharmaceutical composition for treatment or prevention for the early stage of osteoarthritis and its manufacturing method. [Means for solving problem(s)] The present invention is based on a knowledge that the use of an anti-Fas IgM antibody allows the alleviation of an osteoarthritis symptom. Specifically, the present invention is based on a knowledge that the use of an anti-Fas IgM antibody allows the inhibition of production of a cartilage matrix degrading enzyme. Furthermore, the present invention is based on a knowledge that the use of an anti-Fas IgM antibody can improve the ability to produce a cartilage matrix.
AbstractList [Problem(s)] It is an object of the present invention to provide a pharmaceutical composition for treatment or prevention for the early stage of osteoarthritis and its manufacturing method. [Means for solving problem(s)] The present invention is based on a knowledge that the use of an anti-Fas IgM antibody allows the alleviation of an osteoarthritis symptom. Specifically, the present invention is based on a knowledge that the use of an anti-Fas IgM antibody allows the inhibition of production of a cartilage matrix degrading enzyme. Furthermore, the present invention is based on a knowledge that the use of an anti-Fas IgM antibody can improve the ability to produce a cartilage matrix.
Author NISHIOKA KUSUKI
YUDO KAZUO
Author_xml – fullname: NISHIOKA KUSUKI
– fullname: YUDO KAZUO
BookMark eNqNjM0KwjAQhHPQg3_vsOBVwVoEryHdkqLphu3WaykSL0pbqO-PqfgAwsDMMB-zVLOu78JCPb3V7LTBWgqjr2DIeaoKKaiEnBiEUYvDUiAWz3iLcdooB6oESbNYjni1A11m4FAsZdPqmbLafFmxyBjP1mr-aF9j2Px8pbY5irH7MPRNGIf2Hrrwbi58PCRRySk9pzr9j_oAWfs5kQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20120115383A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20120115383A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:54:01 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20120115383A3
Notes Application Number: KR20127021018
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121017&DB=EPODOC&CC=KR&NR=20120115383A
ParticipantIDs epo_espacenet_KR20120115383A
PublicationCentury 2000
PublicationDate 20121017
PublicationDateYYYYMMDD 2012-10-17
PublicationDate_xml – month: 10
  year: 2012
  text: 20121017
  day: 17
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies AXIS, INC
RelatedCompanies_xml – name: AXIS, INC
Score 2.8483405
Snippet [Problem(s)] It is an object of the present invention to provide a pharmaceutical composition for treatment or prevention for the early stage of osteoarthritis...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121017&DB=EPODOC&locale=&CC=KR&NR=20120115383A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFH3UqfhjSkDpk8XuR932MKRLUqqjS8mysbfR1gxksg1X8d_3Ejb1aW9JLxztwSXfl1y-Atw3OnnWaHra1e3UHjPW3LTd8d1W-w3BcprlzdwQxXjwFI2arxN_UoKP7V0YqxP6bcURMaNyzPfCzterv00sZmsr14_ZOz5aPoeqy5wNOzZqWLWWw3pdnggmqENpty-dgbQ2g36QkAV7sG-AtFHa5-OeuZey-r-ohMdwkKC_RXECpfmyAkd0---1ChzGmyNvbG6yb30K8yQKZBxQPlJGxYBQESdi-GI2mQiSOaIkD5QR5yfYwdCOsWlsIiRiqLhA7BpJHD58IMGAkZirSDBjTaRgI1tNQlTEJUdnZ3AXckUjF996-hukaV_-_8TGOZQXy4W-AJJqnSPOqvuzTCMbQkDo52lHm4nFm6Ve_RKquzxd7TZfG6Lr2aq4WqsK5eLzS9_gMl1ktza6P8FCjUI
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4gGvGmqPGBuommJxt51cKBmNJuU4R2m2Uh3khbl8RggEiNf9_ZDSgnbrv9NpN2kpmdbx9fAR4a7SxtNKvSlK1EbzPWzKTVtky79Y7FcpJmzUwRxTB6DkbN1zfrrQCfm7swWif0R4sjYkRlGO-5ztfL_0UsT5-tXD2lH_ho8eKLjmes2bFSw6rZhtft0Jh5zDVct9PnRsQ1pqofJGTOHuzbSAqV0j4dd9W9lOX2pOIfw0GM9ub5CRRmizKU3M2_18pwGK63vLG5jr7VKcziwOGh49KRUCoGxGVhzIY9tchEkMwRwakjlDg_wQ66doxNhTGfsKGgDGvXgOPw4SNxIo-EVATMU2jMmTfSp0mICCinaOwM7n0q3MDEt578OWnS59uf2DiH4nwxlxdAEikzrLPq1jSVyIawILSypC1VYqlOk2r9Eiq7LF3thu-gFIhwMBn0ov41HClIZfaaXYFi_vUtb3DKztNb7elfg8eQMQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION+FOR+TREATMENT+OR+PREVENTION+OF+OSTEOARTHRITIS%2C+AND+METHOD+OF+PRODUCTION+THEREFOR&rft.inventor=NISHIOKA+KUSUKI&rft.inventor=YUDO+KAZUO&rft.date=2012-10-17&rft.externalDBID=A&rft.externalDocID=KR20120115383A